Veterinary Pain Management Market Size, Share, Growth Analysis, By Product(Drugs, and devices), By Animal Type(Companion animals, and livestock animals), By Application(Joint pain, Post-operative Pain, Cancer, and Other Applications), By End User(Veterinary hospitals, Veterinary Clinics, and Pharmacies & Drug Stores), By Region - Industry Forecast 2024-2031

Global Veterinary Pain Management Market size was valued at USD 1.80 billion in 2022 and is poised to grow from USD 1.92 billion in 2023 to USD 3.23 billion by 2031, growing at a CAGR of 6.7 % in the forecast period (2024-2031).

The global veterinary pain management market is characterized by the presence of high-profile international players with innovative products and therapies. The prominent players in the market include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim, Vetoquinol SA and Bayer AG. These firms concentrate on developing advanced medicines, laser therapies, and non-functional implement pains consolation apparatus. Joint ventures, funding of research, and commercialization of new products are some of the strategies employed by market participants to stay ahead of competition in the expanding veterinary pain management market growth. 'Boehringer Ingelheim International Gmbh (Germany) ', 'Elanco Animal Health Incorporated (US) ', 'Dechra Pharmaceuticals (UK) ', 'Vetoquinol (France) ', 'Sequent Scientific Limited (India) ', 'Norbrook Laboratories Limited (UK) ', 'Ceva Santé Animale (France) ', 'Chanelle Pharma (Ireland) ', 'K-Laser USA (US) ', 'Assisi Animal Health (US) ', 'Multi Radiance Medical (US) ', 'Avazzia (US) ', 'Sound Technologies (US) ', 'Ourofino Animal Health (Brazil) ', 'Labindia Healthcare Private Limited (India) ', 'Richter Pharma AG (Austria) ', 'Fidelis Animal Health (US)'

The trends toward globalization of pet ownership and the anthropomorphism of pets are pushing the demand for veterinary pain management solutions. There is a higher willingness of pet owners to seek and engage advanced treatment protocols for their pets, especially to relieve chronic arthritic inflammation or pain following surgery. 

Increased Focus on Non-Invasive Treatment Options: In the global veterinary pain management market trends, one of the main drivers is the growing inclination towards non-invasive treatment procedures, particularly laser therapy and pulsed electromagnetic field therapy. These procedures eliminate undue stress and prolongs the recovery of the patients which satisfies a Chinese pet owner’s desire for efficient and quick pain relief methods with no use of drugs. 

North America dominates the global veterinary pain management market due to its advanced veterinary healthcare infrastructure, high pet ownership rates, and increased awareness of animal welfare. The acute need for pet care services and high expenditure on veterinary services in the region encourages the embrace of advanced techniques for pain alleviation including laser therapy, drugs and alternative treatment modalities. In addition to this, tight animal care policies and the need to enhance livestock productivity and health also elevate the market. Due to the presence of the key active industry participants and endless re-inventing of veterinary drugs and devices, North America remains the number one region for veterinary pain management solutions.